Kent Sally C, Mannering Stuart I, Michels Aaron W, Babon Jenny Aurielle B
Department of Medicine, Division of Diabetes, Diabetes Center of Excellence, ASC7-2041, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy, Victoria, 3065, Australia.
Curr Diab Rep. 2017 Sep 2;17(10):95. doi: 10.1007/s11892-017-0915-y.
Autoimmune-mediated destruction of insulin-producing β-cells within the pancreas results in type 1 diabetes (T1D), which is not yet preventable or curable. Previously, our understanding of the β-cell specific T cell repertoire was based on studies of autoreactive T cell responses in the peripheral blood of patients at risk for, or with, T1D; more recently, investigations have included immunohistochemical analysis of some T cell specificities in the pancreas from organ donors with T1D. Now, we are able to examine live, islet-infiltrating T cells from donors with T1D.
Analysis of the T cell repertoire isolated directly from the pancreatic islets of donors with T1D revealed pro-inflammatory T cells with targets of known autoantigens, including proinsulin and glutamic acid decarboxylase, as well as modified autoantigens. We have assayed the islet-infiltrating T cell repertoire for autoreactivity and function directly from the inflamed islets of T1D organ donors. Design of durable treatments for prevention of or therapy for T1D requires understanding this repertoire.
胰腺内胰岛素生成β细胞的自身免疫介导性破坏会导致1型糖尿病(T1D),目前该病尚无法预防或治愈。以前,我们对β细胞特异性T细胞库的了解基于对有T1D风险或患有T1D患者外周血中自身反应性T细胞反应的研究;最近,研究包括对来自患有T1D器官捐赠者胰腺中某些T细胞特异性的免疫组织化学分析。现在,我们能够检查来自患有T1D捐赠者的活的胰岛浸润T细胞。
对直接从患有T1D捐赠者的胰岛中分离出的T细胞库进行分析,发现了具有已知自身抗原靶点的促炎性T细胞,包括胰岛素原和谷氨酸脱羧酶,以及修饰的自身抗原。我们直接从T1D器官捐赠者发炎的胰岛中检测了胰岛浸润T细胞库的自身反应性和功能。设计用于预防或治疗T1D的持久疗法需要了解这个细胞库。